Cells of the monocyte-macrophage lineage and pathogenesis of HIV- 1 infection

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 22, Issue 5, 1999, Pages 413-429

  Martín, Juan C ^a   Bandrés, Juan C ^a,b  

^a NEW YORK UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Dendritic cells; HIV; Macrophage; Monocyte; Pathogenesis; Receptor

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR5; CYTOKINE;

ARTICLE; CELL LINEAGE; DENDRITIC CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; MACROPHAGE; MONOCYTE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033572458     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199912150-00001     Document Type: Article

References (223)

1. Thomas R, Wong R, Lipsky PE. Monocytes and macrophages. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB, eds. Textbook of rheumatology. Philadelphia: WB Saunders, 1997:128-45.
2. Green SJ, Turpin JA, Nacy CA. Cytotoxic effector activities of macrophages. In: Rich RR, Fleisher TA, Schwarts BD, Shearer W, Strober W, eds. Clinical immunology: principles and practice. St. Louis: Mosby, 1996:290-8.
3. Faller DV, Mentzer SJ. Monocyte and macrophage development and function. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, eds. Hematology: basic principles and practice. New York: Churchill Livingstone, 1995:751-62.
4. Gendelman HE, Orenstein JM, Baca LM, et al. The macrophage in the persistence and pathogenesis of HIV infection. AIDS 1989; 3:475-95.
5. Meltzer MS, Nakamura M, Hansen BD, Turpin JA, Kalter DC, Gendelman HE. J Acquir Immune Defic Syndr 1990;6:967-71.
6. Crowe SM. Role of macrophages in the pathogenesis of human immunodeficiency virus (HIV) infection. Aust NZ J Med 1995; 25:777-83.
7. Rich EA, Chen ISY, Zack JA, Leonard ML, O'Brien WA. Increased susceptibility of differential mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J Clin Invest 1992;89:176-83.
8. Schuitemaker H, Koostra NA, Koppelman MHGM, et al. Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages. J Clin Invest 1992;89:1154-60.
9. Cunningham AL, Naif H, Saksena N, et al. HIV infection of macrophages and pathogenesis of AIDS dementia complex: interaction of the host cell and viral genotype. J Leukoc Biol 1997; 62:117-25.
10. Sonza S, Maerz A, Deacon N, Meanger J, Mills J, Crowe S. Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J Virol 1996;70:3863-9.
11. Weimberg JB, Mathews TJ, Cullen BR, Malim MH. Productive human immunodeficiency virus type 1 (HIV-1) infection of non-proliferating human monocytes. J Exp Med 1991;174:1477-82.
12. Donaldson YK, Bell JE, Ironside JW, et al. Redistribution of HIV outside the lymphoid system with onset of AIDS. Lancet 1994; 343:382-5.
13. Sei S, Kleiner DE, Kopp JB, et al. Quantitative analysis of viral burden in tissues from adults and children with symptomatic human immunodeficiency virus type 1 infection assessed by polymerase chain reaction. J Infect Dis 1994;170:325-33.
14. Koening S, Gendelman HE, Orenstein JM, et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986;233:1089-93.
15. Vazeux R, Jarry A, Henin D, et al. AIDS subacute encephalitis. Identification of HIV-infected cells. Am J Pathol 1987;126:403-10.
16. Cao Y, Dieterich D, Thomas PA, Huang Y, Mirabile M, Ho DD. Identification and quantification of HIV-1 in the liver of patients with AIDS. AIDS 1992;6:65-70.
17. Smith PD, Fox CH, Masur H, Winter HS, Ailing DW. Quantitative analysis of mononuclear cells expressing human immunodeficiency virus type 1 RNA in esophageal mucosa. J Exp Med 1994;180:1541-6.
18. Jarry A, Cortez A, René E, Muzeau F, Brousse N. Infected cells and immune cells in the gastrointestinal tract of AIDS patients. An immunohistochemical study of 127 cases. Histopathology 1990;16:133-40.
19. Lewin SR, Kirihara J, Sonza S, Irving L, Mills J, Crowe SM. HIV-1 DNA and mRNA concentrations are similar in peripheral blood monocytes and alveolar macrophages in HIV-1-infected individuals. AIDS 1998;12:719-27.
20. Moreno P, Rebollo MJ, Pulido F, Rubio R, Noriega AR, Delgado R. Alveolar macrophages are not an important source of viral production in HIV-1 infected patients. AIDS 1996;10:682-4.
21. Lebargy F, Branellec A, Deforges L, Bignon J, Bernaudin JF. HIV-1 in human alveolar macrophages from infected patients is latent in vivo but replicates after in vitro stimulation. Am J Respir Cell Mol Biol 1994;10:72-8.
22. + T lymphocytes in spleens of human immunodeficiency virus-positive patients. J Virol 1995;69:4737-45.
23. Schnittman SM, Psallidopoulos MC, Lane HC, et al. The reservoir for HIV-1 in human peripheral blood is a cell that maintains expression of CD4. Science 1989;245:305-8.
24. Spear GT, Ou CY, Kessler HA, Moore JL, Schochetman G, Landay AL. Analysis of lymphocytes, monocytes, and neutrophils from human immunodeficiency virus (HIV)-infected persons for HIV DNA. J Infect Dis 1990;162:1239-44.
25. Innocenti P, Ottmann M, Morand P, Leclercq P, Seigneurin JM. HIV-1 in blood monocytes: frequency of detection of proviral DNA using PCR and comparison with the total CD4 count. AIDS Res Hum Retroviruses 1992;8:261-8.
26. Hufert FT, Laer DV, Schramm C, Tárnok A, Schmitz H. Detection of HIV-1 DNA in different subsets of human peripheral blood mononuclear cells using the polymerase chain reaction. Arch Virol 1989;106:341-5.
27. Patterson BK, Mosiman VL, Cantarero L, Furtado M, Bhattacharya M, Goolsby C. Detection of HIV-RNA-positive monocytes in peripheral blood of HIV-positive patients by simultaneous flow cytometric analysis of intracellular HIV RNA and cellular immunophenotype. Cytometry 1998;31:265-74.
28. Lewin SR, Lambert P, Deacon NJ, Mills J, Crowe SM. Constitutive expression of p50 homodimer in freshly isolated human monocytes decreases with in vitro and in vivo differentiation: a possible mechanism influencing human immunodeficiency virus replication in monocytes and mature macrophages. J Virol 1997; 71:2114-9.
29. Orenstein JM, Meltzer MS, Phipps T, Gendelman HE. Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study. J Virol 1988;62:2578-86.
30. Gendelman HE, Orenstein JM, Martin MA, et al. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med 1988;167:1428-41.
31. Mostad SB, Kreiss JK. Shedding of HIV-1 in the genital tract. AIDS 1996;10:1305-15.
32. Goulston C, McFarland W, Katzenstein D. Human immunodeficiency virus type 1 RNA shedding in the female genital tract. J Infect Dis 1998;177:1100-3.
33. Mermin JH, Holodniy M, Katzenstein DA, Merigan TC. Detection of human immunodeficiency virus DNA and RNA in semen by the polymerase chain reaction. J Infect Dis 1991;164:769-72.
34. Tan X, Phillips DM. Cell-mediated infection of cervix derived epithelial cells with primary isolates of human immunodeficiency virus. Arch Virol 1996;141:1177-89.
35. Pomerantz RJ, de la Monte SM, Donegan SP, et al. Human immunodeficiency virus (HIV) infection of the uterine cervix. Ann Intern Med 1988;108:321-7.
36. Vernon SD, Zaki SR, Reeves WC. Localization of HIV-1 to human papillomavirus associated cervical lesions. Lancet 1994; 344:954-5.
37. Spira A, Marx PA, Patterson BK, et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med 1996;183:215-25.
38. Chakrabarti L, Isola P, Cumot MC, et al. Early stages of simian immunodeficiency virus infection in lymph nodes. Evidence for high viral load and successive populations of target cells. Am J Pathol 1994;144:1226-37.
39. Reimann KA, Tenner-Racz K, Racz P, et al. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J Virol 1994;68:2362-70.
40. Fox CH, Kotler D, Tierney A, Wilson CS, Fauci AS. Detection of HIV-1 RNA in the lamina propria of patients with AIDS and gastrointestinal disease. J Infect Dis 1989;159:467-71.
41. Ullrich R, Zeitz M, Heise W, L'age M, Höffken G, Riecken EO. Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-inducted enteropathy. Ann Intern Med 1989;111:15-21.
42. Clayton F, Reka S, Cronin WJ, Torlakovic E, Sigal SH, Kotler DP. Rectal mucosal pathology varies with human immunodeficiency virus antigen content and disease stage. Gastroenterology 1992;103:919-33.
43. Nelson JA, Wiley CA, Reynolds-Kohler C, Reese CE, Margaretten W, Levy JA. Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms. Lancet 1988;1:259-62.
44. Mathijs JM, Hing M, Grierson J, et al. HIV infection of rectal mucosa. Lancet 1988;1:1111.
45. Kotler DP, Reka S, Borcich A, Cronin WJ. Detection, localization, and quantification of HIV-associated antigens in intestinal biopsies from patients with HIV. Am J Pathol 1991;139:823-30.
46. Amerongen HM, Weltzin R, Farner CM, Michetti P, Haseltine WA, Neutra MR. Transepithelial transport of HIV-1 by intestinal M cells: a mechanism for transmission of AIDS. J Acquir Immune Defic Syndr 1991;4:760-5.
47. Schneider T, Ullrich R, Zeitz M. The immunologic aspects of human immunodeficiency virus infection in the gastrointestinal tract. Semin Gastrointest Dis 1996;7:19-29.
48. Li L, Smith PD. Immunology of mucosal HIV-1 infection. Curr Opin Gastroenterol 1996;12:560-3.
49. Gill MJ, Sutherland LR, Church DL, and The University of Calgary Gastrointestinal/HIV Study Group. Gastrointestinal tissue cultures for HIV in HIV-infected/AIDS patients. AIDS 1992;6: 553-6.
50. Pantaleo G, Cohen OJ, Schacker T, et al. Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: implications for antiviral therapy. Nat Med 1998;4:341-5.
51. Embretson J, Zupancic M, Ribas JL, et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993;362:359-62.
52. Smith PD, Meng G, Shaw GM, Li L. Infection of gastrointestinal tract macrophages by HIV-1. J Leukoc Biol 1997;62:72-7.
53. Hufert FT, Schmitz J, Schreiber M, Schmitz H, Rácz P, von Laer DD. Human Kupffer cells infected with IV-1 in vivo. J Acquir Immune Defic Syndr 1993;6:772-7.
54. Prvot S, Fournier JG, Tardivel I. Detection by in situ hybridization of HIV 1 RNA in spleens of HIV 1 sero-positive patients with thrombocytopenic purpura. Pathol Res Pract 1989;185:187-93.
55. Cheyner R, Henrichwark S, Hadida F, et al. HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes. Cell 1994;78:373-87.
56. Epstein LG, Kuiken C, Blumberg BM, et al. HIV-1 V3 domain variation in brain and spleen of children with AIDS: Tissue-specific evolution within host-determined quasispecies. Virology 1991;180:583-90.
57. Housset C, Lamas E, Courgnaud V, et al. Presence of HIV-1 in human parenchymal and non-parenchymal liver cells in vivo. J Hepatol 1993;19:252-8.
58. Stahmer I, Ordoñez C, Popovic M, et al. SIV infection of monkey spleen cells including follicular dendritic cells in different stages of disease. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 11:1-9.
59. Agostini C, Sancetta R, Cerutti A, Semenzato G. Alveolar macrophages as a cell source of cytokine hyperproduction in HIV-related interstitial lung disease. J Leukoc Biol 1995;58:495-500.
60. Nakata K, Weiden M, Harkin T, Ho D, Rom WN. Low copy number and limited variability of proviral DNA in alveolar macrophages from HIV-1 infected patients: Evidence for genetic differences in HIV-1 between lung and blood macrophage populations. Mol Med 1995;1:744-57.
61. Landay AL, Schade SZ, Takefman DM, et al. Detection of HIV-1 provirus in bronchoalveolar lavage cells by polymerase chain reaction. J Acquir Immune Defic Syndr 1993;6:171-5.
62. Denis M, Ghadirian E. Interleukin 13 and interleukin 4 protect bronchoalveolar macrophages from productive infection with human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1994;10:795-802.
63. Meltzer MS, Kornbluth RS, Hansen B, Dhawan S, Gendelman HE. HIV infection of the lung. Role of virus-infected macrophages in the pathophysiology of pulmonary disease. Chest 1993;103(Suppl):103S-8.
64. Dal Canto MC. Mechanisms of HIV infection of the central nervous system and pathogenesis of AIDS-dementia complex. Neuroimaging Clin North Am 1997;7:231-41.
65. Nottet HSLM, Bär DR, van Hassel H, Verhoef J, Boven LA. Cellular aspects of HIV-1 infection of macrophages leading to neuronal dysfunction in in vitro models for HIV-1. J Leukoc Biol 1997;62:107-16.
66. Tyor WR, Wesseling SL, Griffin JW, McArthur JC, Griffin DE. Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:379-88.
67. Nottet HSLM, Persidsky Y, Sasseville VG, et al. Mechanisms for the transendothelial migration of HIV-1 infected monocytes into brain. J Immunol 1996;156:1284-95.
68. Lipton SA, Gendelman HE. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 1995;332: 934-40.
69. Brack-Werner R. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS 1999;13:1-22.
70. Moses A, Nelson J, Bagby GC Jr. The influence of human immunodeficiency virus-1 on hematopoiesis. Blood 1998;91:1479-95.
71. + human marrow cells is induced by interferon-γ and tumor necrosis factor a and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 1995;85: 3183-90.
72. Saag MS, Hahn BH, Gibbons J, et al. Extensive variation of human immunodeficiency virus type-1 in vivo. Nature 1988;334: 440-4.
73. Meyerhans A, Cheynier R, Albert J, et al. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 1989;58:901-10.
74. Koyanagi Y, Miles S, Mitsuyasu RT, Merrill JE, Vinters HV, Chen ISY. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropism. Science 1987;236:819-22.
75. Cheng-Mayer C, Seto D, Tateno M, Levy JA. Biologic features of HIV-1 that correlate with virulence in the host. Science 1988; 240:80-2.
76. Cho MW, Lee MK, Carney MC, Berson JF, Doms RW, Martin MA. Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4. J Virol 1998;72:2509-15.
77. Cheng-Mayer C, Weiss C, Seto D, Levy JA. Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus. Proc Natl Acad Sci USA 1989; 86:8575-9.
78. Fisher AG, Ensoli B, Looney D, et al. Biologically diverse molecular variants within a single HIV-1 isolate. Nature 1988;334: 444-8.
79. Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M. The role of mononuclear phagocytes in HTLV-III/ LAV infection. Science 1986;233:215-9.
80. Schuitemaker H, Koot M, Koostra NA, et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J Virol 1992;66:1354-60.
81. Schuitemaker H, Koostra NA, de Goede REY, de Wolf F, Miedema F, Tersmette M. Monocytotropic human immunodeficiency virus (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J Virol 1991;65:356-63.
82. Fenyö EM, Morfeldt-Månson L, Chiodi F, et al. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J Virol 1988;62:4414-9.
83. Broder CC, Collman RG. Chemokine receptors and HIV. J Leukoc Biol 1997;62:20-9.
84. Van't Woult AB, Blaak H, Ran LJ, Brouwer M, Kuiken C, Schuitemaker H. Evolution of syncytium-inducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection. J Virol 1998;72:5099-107.
85. Cornelissen M, Mulder-Kampinga G, Veenstra J, et al. Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population. J Virol 1995;69:1810-8.
86. Veenstra J, Schuurman R, Cornelissen M, et al. Transmission of zidovudine-resistant human immunodeficiency virus type 1 variants following deliberate injection of blood from a patient with AIDS: characteristics and natural history of the virus. Clin Infect Dis 1995;21:556-60.
87. Zhu T, Mo H, Wang N, et al. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 1993;261:1179-81.
88. Connor RI, Ho DD. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J Virol 1994;68: 4400-8.
89. Valentin A, Fenyö EM, Asjö B. Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates. J Virol 1994;68:6684-9.
90. Simmons G, Wilkinson D, Reeves JD, et al. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual tropics and most can use either Lestr or CCR5 as coreceptors for virus entry. J Virol 1996;70:8355-60.
91. Connor RI, Sheridan KE, Geradini D, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 1997;185:621-8.
92. Tersmette M, de Goede REY, Al BJM, et al. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Virol 1988;62:2026-32.
93. Tersmette M, Gruters RA, de Wolf F, et al. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential isolates. J Virol 1989;63:2118-25.
94. Richman DD, Bozzete SA. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J Infect Dis 1994;169:968-74.
95. + T cell depletion and virus syncytium-inducing/non-syncytium-inducing phenotype in histocultures inoculated with laboratory strains and patient isolates of HIV type 1. AIDS Res Hum Retroviruses 1997;13:461-71.
96. Pal A, Greenough TC, Sullivan JL, Somasundaran M. In vitro characterization of adult primary human immunodeficiency virus type 1: demonstration of distinctive single-cell killing phenotypes in spite of similar levels of viral replication. J Infect Dis 1997; 176:933-40.
97. Blaak H, Brouwer M, Ran LJ, de Wolf F, Schuitemaker H. In vitro relation kinetics of human immunodeficiency virus type 1 (HIV-1) variants in relation to virus load in long-term survivors of HIV-1 infection. J Infect Dis 1998;177:600-10.
98. Berger EA, Doms RW, Fenyö EM, et al. A new classification for HIV-1. Nature 1998;391:240.
99. Deng HK, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996;381: 661-6.
100. Stent G, Joø GB, Keirulf P, Osjö B. Macrophage tropism: fact or fiction? J Leukoc Biol 1997;62:4-11.
101. Di Fronzo NL, Pise-Masison CA, Fernandez-Larsson R, Holland CA. Viral determinants of HIV-1 sufficient to extend tropism to macrophages are distinct from the determinants that control the cytopathic phenotype in HL-60 cells. AIDS 1997;11:1681-8.
102. Zhang L, Huang Y, He T, Cao Y, Ho DD. HIV-1 subtype and second-receptor use. Nature 1996;383:768.
103. Scarlati G, Tresoldi E, Björndal Å, et al. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediate suppression. Nat Med 1997;3:1259-65.
104. Rucker J, Edinger AI, Sharron M, et al. Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses. J Virol 1997;71:8999-9007.
105. Choe H, Farzan M, Sun Y, et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-48.
106. Cocchi F, DeVico AL, Garzino-Demo A, Cara A, Gallo RC, Lusso P. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat Med 1996;2:1244-7.
107. Groenink M, Founchier RAM, Broersen S, et al. Relation of phenotype evolution of HIV-1 to envelope V2 configuration. Science 1993;260:1513-6.
108. Cheng-Mayer C, Liu R, Landau NR, Stamatatos L. Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor. J Virol 1997;71:1657-61.
109. Moore JP, Binley J. Envelope's letters boxed into shape. Nature 1998;393:630-1.
110. HxB. J Virol 1997;71:5678-683.
111. Lu ZH, Bersun JF, Chen YH, et al. Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains. Proc Natl Acad Sci USA 1997;94:6426-31.
112. Dittmar MT, McKnight Á, Simmons G, Clapham PR, Weiss RA, Simmonds P. HIV-1 tropism and co-receptor use. Nature 1997; 385:495-6.
113. Doranz BJ, Rucker J, Yi Y, et al. A Dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR3, and CKR-2b as fusion cofactors. Cell 1996;85:1149-58.
114. Alkhatib G, Combadiere C, Broder CC, et al. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-8.
115. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-73.
116. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry Co-factor. Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:872-7.
117. Bleul CC, Farzan M, Choe H, et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996;382:829-33.
118. Oberlin E, Amara A, Bachelerie F, et al. The CXC chemokine SDF-1 is a ligand for LSTR/fusing and prevents infection by T-cell-line-adapted HIV-1. Nature 1996;382:833-5.
119. Moore JP, Trkola A, Dragic T. Co-receptors for HIV-1 entry. Curr Opin Immunol 1997;9:551-62.
120. Zhang L, He T, Talal A, Wang G, Frankel SS, Ho DD. In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5. J Virol 1998;72:5035-45.
121. Bleul CC, Wu L, Hoxie JA, Springer TA, Mackay CR. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA 1997;94:1925-30.
122. Wu L, Paxton WA, Kassam N, et al. CR. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 1997;185:1681-91.
123. Lapham CK, Zaitseva MB, Lee S, Romanstseva T, Golding H. Fusion of monocytes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5. Nat Med 1999;5:303-8.
124. + T cells and monocytes from cord and adult blood. AIDS Res Hum Retroviruses 1998;14:607-17.
125. Bermejo M, Martín-Serrano J, Oberlin E, et al. Activation of blood T lymphocytes down-regulates CXCR4 expression and interferes with propagation of X4 HIV strains. Eur J Immunol 1998; 28:3192-204.
126. Hesselgesser J, Liang M, Hoxie J, et al. Identification and characterization of the CXCR4 chemokine receptor in human T cell lines: ligand binding, biological activity, and HIV-1 infectivity. J Immunol 1998;160:877-83.
127. Tuttle DL, Harrison JK, Anders C, Sleasman JW, Goodenow MM. Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1. J Virol 1998;72: 4962-9.
128. Fear WR, Kesson AM, Naif H, Lynch GW, Cunningham AL. Differential tropism and chemokine receptor expression of human immunodeficiency virus type 1 in neonatal monocytes, monocyte-derived macrophages, and placental macrophages. J Virol 1998;72:1334-44.
129. Naif HM, Li S, Alali M, et al. CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J Virol 1998;72:830-6.
130. Zaitseva M, Blauvelt A, Lee S, et al. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nat Med 1997;3:1369-75.
131. Clapham PR, Weiss RA. Spoilt for choice of co-receptors. Nature 1997;388:230-1.
132. Yi Y, Rana S, Turner JD, Gaddis N, Collman RG. CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1. J Virol 1998;72:772-7.
133. Deng HK, Unutmaz D, Kewal-Ramani VN, Littman DR. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 1997;388:296-300.
134. Di Marzio P, Tse J, Landau NR. Chemokine receptor regulation and HIV type 1 tropism in monocyte-macrophages. AIDS Res Hum Retroviruses 1998;14:129-38.
135. Simmons G, Reeves JD, McKnight Á, et al. CXCR4 as a functional coreceptor for human immunodeficiency virus type 1 infection of primary macrophages. J Virol 1998;72:8453-7.
136. Platt EJ, Wehrly K, Kuhmann SE, Chesebro B, Kabat D. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophage-tropic isolates of human immunodeficiency virus type 1. J Virol 1998;72:2855-64.
137. Bandrés JC, Wang QF, O'Leary J, et al. Human immunodeficiency virus (HIV) envelope binds to CXCR4 independently of CD4, and binding can be enhanced by interaction with soluble CD4 or by HIV envelope deglycosylation. J Virol 1998;72:2500-4.
138. Kozak SL, Platt EJ, Madani N, Ferro FE Jr, Peden K, Kabat D. CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1. J Virol 1997;71:873-82.
139. Bastiani L, Laal S, Kim M, Zolla-Pazner S. Host cell-dependent alterations in envelope components of human immunodeficiency virus type 1 virions. J Virol 1997;71:3444-50.
140. Fortin JF, Cantin R, Tremblay MJ. T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1. J Virol 1998;72:2105-12.
141. Hioe CE, Bastiani L, Hildreth JEK, Zolla-Pazner S. Role of cellular adhesion molecules in HIV type 1 infection and their impact on virus neutralization. AIDS Res Hum Retroviruses. 1998;14: S247-S54.
142. Schmidtmayerova H, Alfano M, Nuovo G, Bukrinsky M. Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4-and CXCR4-mediated pathway: replication is restricted at a postentry level. J Virol 1998;72:4633-42.
143. Moore JP. Coreceptors: Implications for HIV. Pathogenesis and therapy. Science. 1997;276:51-2.
144. Sol N, Ferchal F, Braun J, et al. Usage of the coreceptors CCR-5, CCR-3, and CXCR-4 by primary and cell line-adapted human immunodeficiency virus type 2. J Virol 1997;71:8237-44.
145. Steward G. Chemokine genes-beating the odds. Nat Med 1998; 4:275-7.
146. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion of the CKR5 structural allele. Science 1996;273:1856-62.
147. Huang Y, Paxton WA, Wolinsky SM, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996;2:1240-3.
148. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996;382:722-5.
149. Biti R, French R, Young J, Bennetts B, Stewart G. HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nat Med 1997;3:252-3.
150. O'Brien TR, Winkler C.Dean M, et al. HIV-1 infection in a man homozygous for CCR-5Δ32. Lancet 1997;349:1219.
151. Theodorou I, Meyer L, Magierowska M, Katlana C, Rouzioux C, and the Seroco Study Group. HIV-1 infection in an individual homozygous for CCR5Δ32. Lancet 1997;349:1219-20.
152. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86:367-77.
153. Paxton WA, Martin SR, Tse D, et al. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nature Med 1996;2:412-7.
154. Michael N, Nelson JAE, Kewalramani VN, et al. Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5Δ32. J Virol 1998;72:6040-7.
155. Naif HM, Alali M, Li S, French R, Stewart G, Cunningham A. Tropism, characterization, and co-receptor usage of an HIV-1 isolate derived from HIV positive person homozygous for CCR5Δ32 [abstract 11112]. XII International Conference on AIDS, Geneva, Switzerland, 1998.
156. Bolognesi DP. HIV: A clever hijacker of the immune system. Curr Opin Immunol 1997;9:549-50.
157. Atchison RE, Gosling J, Montecarlo FS, et al. Multiple extracellular elements of CCR5 and HIV-1 entry: Dissociation from response to chemokines. Science 1996;274:1924-6.
158. Doranz BJ, Lu ZH, Rucker J, et al. Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1. J Virol 1997;71:6305-14.
159. Edinger AL, Amedee A, Miller K, et al. Differential utilization of CCR5 by macrophage and T-cell tropic SIV strains. Proc Natl Acad Sci USA 1997;94:4005-10.
160. Rucker J, Samson M, Doranz BJ, et al. Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 1996;87:437-46.
161. Doms RW, Peiper SC. Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry. Virology 1997;235:179-90.
162. Rabut GEE, Konner JA, Kajumo F, Moore JP, Dragic T. Alanine substitutions of polar and nonpolar residues in the amino-terminal domain of CCR5 differently impair entry of macrophage-and dualtropic isolates of human immunodeficiency virus type 1. J Virol 1998;72:3464-8.
163. Genoud S, Kajumo F, Guo Y, Thompson D, Dragic T. CCR5-mediated human immunodeficiency virus entry on an amino-terminal gp120-binding site and on the conformational integrity of all four extracellular domains. J Virol 1999;73:1645-8.
164. Hladik F, Lenzt G, Akrioge RE, Kelly H, McElroy A, McElrath J. Co-receptors and cellular targets for HIV-1 entry in the human female genital tract [abstract 10*/11106]. XII World Conference on AIDS, Geneva, Switzerland, 1998.
165. Granelli-Piperno A, Moser B, Pope M, et al. Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors. J Exp Med 1996;184:2433-8.
166. Sozzani S, Luini W, Borsatti A, et al. Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J Immunol 1997;159:1993-2000.
167. Cameron PU, Lowe MG, Sotzik F, Coughlan AF, Crowe SM, Shortman K. The interaction of macrophage and non-macrophage tropic isolates of HIV-1 with thymic and tonsillar dendritic cells in vitro. J Exp Med 1996;183:1851-6.
168. + T cells with the human immunodeficiency virus: use of dendritic cells from individuals homozygous for the Δ32CCR5 allele as a model. AIDS Res Hum Retroviruses 1998;14:1109-13.
169. Kacani L, Frank I, Spruth M, et al. Dendritic cells transmit human immunodeficiency virus type 1 to monocytes and monocyte-derived macrophages. J Virol 1998;72:6671-7.
170. Schmidtmayerova H, Sherry B, Bukrinsky M. Chemokines and HIV replication. Nature 1996;382:767.
171. + T-cell-derived factor(s), but not beta-chemokines RANTES, MIP-1alpha, and MIP-1beta, suppress HIV-1 replication in monocyte/macrophages. Proc Natl Acad Sci USA 1996; 93:15341-5.
172. Verani A, Scarlati G, Comar M, et al. C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. J Exp Med 1997;185:805-16.
173. De Roda-Husman AM, Koot M, Cornelissen M, et al. Association between CCR5 genotype and the clinical course of HIV-1 infection. Ann Intern Med 1997;127:882-90.
174. Walli R, Reinhart B, Luckow B et al. HIV-1 infected long-term slow progressors heterozygous for Δ32-CCR5 show significantly lower plasma
175. Horuk R. Chemokine receptors and HIV-1: the fusion of two major research fields. Immunol Today 1999;20:89-94.
176. Glushakova S, Grivel JC, Fitzgerald W, Sylwester A, Zimmerberg J, Margolis LB. Evidence for the HIV-1 phenotype switch as a casual factor in acquired immunodeficiency. Nat Med 1998;4: 346-9.
177. Itescu S, Simonelli PF, Winchester RJ, Ginsberg HS. Human immunodeficiency virus type 1 strains in the lungs of infected individuals evolve independently from those in peripheral blood and are highly conserved in the C-terminal region of the envelope V3 loop. Proc Natl Acad Sci USA 1994;91:11378-82.
178. Agostini C, Semenzato G. Immunologic effects of HIV in the lung. Clin Chest Med 1996;17:633-45.
179. Korber BTM, Kunstman KJ, Patterson BK, et al. Genetic differences between blood-and brain-derived viral sequences from Human Immunodeficiency Virus type-1 infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol 1994;68:7467-81.
180. Keys B, Karis J, Fadeel B, et al. V3 sequences of paired HIV-1 isolates from blood and cerebrospinal fluid cluster according to host and show variation related to the clinical stage of the disease. Virology 1993;196:475-83.
181. He J, Chen Y, Farzan M, et al. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 1997;385:645-9.
182. Ghorpade A, Nukuna A, Che M, et al. Human immunodeficiency virus neurotropism: an analysis of viral replication and cytopathicity for divergent stains in monocytes and microglia. J Virol 1998;72:3340-50.
183. Vicenzi E, Biswas P, Mengozzi M, Poli G. Role of proinflammatory cytokines and beta-chemokines in controlling HIV replication. J Leukoc Biol 1997;62:34-40.
184. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996;384:529-34.
185. Gesani S, Borghi P, Fantuzzi L, et al. Induction of cytokines by HIV-1 and its gp120 protein in human peripheral blood monocyte/macrophages and modulation of cytokine response during differentiation. J Leukoc Biol 1997;62:49-53.
186. Poli G, Fauci AS. The role of cytokines in the pathogenesis of HIV disease and therapy. In: Aggarwal BB, Puri RK. Human cytokines: their role in health and human disease, 1st ed, vol 1. Cambridge, MA: Blackwell Scientific, 1995:421-48.
187. Wang J, Roderiquez G, Oravecz T, Norcross MA. Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression. J Virol 1998;72:7642-7.
188. Zella D, Barabitskaja O, Burns JM, et al. Interferon-gamma increases expression of chemokine receptors CCR1, CCR3, and CCR5, but not CXCR4 in monocytoid U937 cells. Blood 1998; 91:4444-50.
189. Grove M, Plumb M. C/EBP, NF-kB, and c-Ets family members and transcriptional regulation of the cell-specific and inducible macrophage inflammatory protein 1alpha immediate-early gene. Mol Cell Biol 1993;13:5276-89.
190. Moriuchi H, Moriuchi M, Fauci AS. Nuclear factor-kB potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J Immunol 1997;158:3483-91.
191. Capobianchi MR, Abbate I, Antonelli G, Turrizani O, Dolei A, Dianzani F. Inhibition of HIV type 1 BaL replication by MIP-1α, MIP-1β, and RANTES in macrophages. AIDS Res Hum Retroviruses 1998;14:233-40.
192. Saha K, Volsky DJ. Are beta-chemokines innocent bystanders in HIV type 1 disease progression?. AIDS Res Hum Retroviruses 1998;14:1-2.
193. Ullum H, Lepri AC, Victor J, et al. Production of beta-chemokines in human immunodeficiency virus (HIV) infection: evidence that high levels of macrophage inflammatory protein-1alpha are associated with a decreased risk of HIV disease progression. J Infect Dis 1998;177:331-6.
194. Tartakovsky B, Turner D, Vardinon N, Burke M, Yust I. Increased intracellular accumulation of macrophage inflammatory protein 1alpha and its decreased secretion correlate with advanced HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20:420-2.
195. +, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro. J Virol 1998;72:876-81.
196. Iversen AKN, Fugger L, Eugen-Olsen J, et al. Cervical human immunodeficiency virus type 1 shedding is associated with genital beta-chemokine selection. J Infect Dis 1998;178:1334-42.
197. Schmidtmayerova H, Nottet HSLM, Nuovo G, et al. Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: Implications for recruitment of leukocytes into brain and lymph nodes. Proc Natl Acad Sci USA 1996;93:700-4.
198. Gordon CJ, Muesing MA, Proudfoot AEI, Power CA, Moore JP, Trkola A. Enhancement of human immunodeficiency virus type 1 infection by the CC-chemokine RANTES is independent of the mechanism of virus-cell fusion. J Virol 1999;73:684-94.
199. Nelson PJ, Krensky AM. Chemokines, lymphocytes and viruses: what goes around, comes around. Curr Opin Immunol 1998; 10: 265-70.
200. Proost P, de Meester I, Schols D, et al. Amino-terminal truncation of chemokines by CD26/dipeptidil-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. J Biol Chem 1998;273:7222-7.
201. Dolei A, Biolchini A, Serra C, Curreli S, Gomes E, Dianzani F. Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1alpha, MIP-1beta and RANTES beta-chemokines. AIDS 1998;12:183-90.
202. Winkler C, Modi W, Smith MW, et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. Science 1998;279:389-93.
203. Hart DNJ. Dendritic cells: unique leukocyte populations with control the primary immune response. Blood 1997;90:3245-87.
204. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52.
205. Weissman D, Fauci AS. Role of dendritic cells in immunopathogenesis of human immunodeficiency virus infection. Clin Microbiol Rev 1997;10:358-67.
206. Clark EA. HIV: Dendritic cells as embers for the infectious fire. Curr Biol 1996;6:655-7.
207. Palucka KA, Taquet N, Sanchez-Chapuis F, Gluckman JC. Dendritic cells as the terminal stage of monocyte differentiation. J Immunol 1998;160:4587-95.
208. + dendritic cells. Proc Natl Acad Sci USA 1996;93:2588-92.
209. +CD38-lin-cord blood cells develop into dendritic cells in human thymic stromal monolayers and thymic nodules. J Immunol 1998;160:3290-8.
210. Knight SC, Elsley W, Wang H. Mechanisms of loss of functional dendritic cells in HIV-1 infection. J Leukoc Biol 1997;62:78-81.
211. + stem cells. J Acquir Immune Defic Syndr 1999;21: 179-88.
212. Grouard G, Clark EA. Role of dendritic and follicular dendritic cells in HIV infection and pathogenesis. Curr Opin Immunol 1997;9:563-7.
213. Kripke ML, Munn CG, Jeevan A, Tang JM, Bucana C. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J Immunol 1990;145:2833-8.
214. Zambruno G, Giannetti A, Bertazzoni U, Girolomoni G. Langerhans cells and HIV infection. Immunol Today 1995;16:520-4.
215. Blauvelt A, Katz SI. The skin as target, vector, and effector organ in human immunodeficiency virus disease. J Invest Dermatol 1995;105(Suppl):122S-6.
216. Frankel SS, Wening BM, Burke AP, et al. Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid. Science 1996;272:115-7.
217. Pope M, Betjes MGH, Romani N, et al. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 1994;78:389-98.
218. + T cells. J Immunol 1995;155:4111-7.
219. Fauci AS, Pantaleo G, Stanley S, Weissman D. Immunopathogenic mechanisms of HIV infection. Ann Intern Med 1996;124: 654-63.
220. Pantaleo G, Graziosi C, Demarest JF, et al. Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection. Immunol Rev 1994;140:105-30.
221. Pantaleo G, Graziosi C, Damarest JF, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993;362:355-8.
222. Schmitz J, van Luzen J, Tenner-Racz K, et al. Follicular dendritic cells retain HIV-1 particles on their plasma membrane, but are not productively infected in asymptomatic patients with follicular hyperplasia. J Immunol 1994;153:1352-9.
223. Tacchetti C, Favre A, Moresco L, et al. HIV is trapped and masked in the cytoplasm of lymph node follicular dendritic cells. Am J Pathol 1997;150:533-42.